TrialThe Lancet. Oncology2022

Single-dose carboplatin followed by involved-node radiotherapy for stage IIA and stage IIB seminoma (SAKK 01/10): a single-arm, multicentre, phase 2 trial.

Alexandros Papachristofilou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.